RxDoctor Payments DataLook up a doctor →

Michelle Diaz

Adult Health · White Plains, MDNPI 1063099547

Payments from drug & device makers

$17,821in general payments, 2019–2025

Across 829 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • GSK$2K
  • Sanofi$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$993
  • Boehringer Ingelheim$911
  • Jazz Pharmaceuticals Inc.$898
  • plus $7K from 25 others

What the payments were for

  • Food & beverage$17,32997%
  • Education$4923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$17,821 in reported general payments places this provider in the 95th percentile of 542 adult health providers in Maryland.

See all adult health providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter341$336,639
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$23,091
Spiriva RespimatTiotropium Bromide24$20,936
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$15,066
Breo ElliptaFluticasone/Vilanterol20$10,664
Albuterol Sulfate HfaAlbuterol Sulfate325$9,481
Arnuity ElliptaFluticasone Furoate24$9,020
Advair HfaFluticasone Propion/Salmeterol13$6,438
Fluticasone-SalmeterolFluticasone Propion/Salmeterol35$4,690
SymbicortBudesonide/Formoterol Fumarate14$3,778
Wixela InhubFluticasone Propion/Salmeterol30$3,117
Montelukast Sodium176$2,819
Roflumilast28$2,113
Azelastine-FluticasoneAzelastine/Fluticasone20$2,081
Ventolin HfaAlbuterol Sulfate21$1,266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$2,257$371,390412 claims
AstraZenecaBreztri Aerosphere, Symbicort$3,725$26,86944 claims
Boehringer IngelheimSpiriva Respimat$911$20,93624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 542 adult health providers in Maryland.

Other adult health in White Plains

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →